Zelira Therapeutics Ltd has released a press release.
R&D Tax Incentive Refund
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- ZLD Partners with SprinJene to Launch CBD Toothpaste in US
- Emyria Deal and Autism Observational Trial for HOPE Products
- September 2020 Quarterly Report
- HOPE launches in Australia after TGA approves release
- Thorney Becomes a Substantial Strategic Investor in Zelira
Later from Zelira Therapeutics
- Zelira Expands HOPE Distribution to Washington DC, USA
- December 2020 Quarterly Report
- Strategic Transition and Executive Changes
- Appendix 4D & FY21 Interim Financial Report
- Zelira Announces Record Third Quarter Revenue
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics